Recent Updates
Recently added Catalysts
CDNA Positive Sentiment

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Friday, November 6, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CareDx, Inc. announced the award of inducement grants under Nasdaq Listing Rule 5635(c)(4). On November 5, 2026, the company granted restricted stock units (RSUs) to 21 new employees, totaling 33,375 shares. The RSUs will vest over four years, with a quarter vesting on the first anniversary.

Market Sentiment Analysis

POSITIVE FACTORS

  • CareDx awarded RSUs to 21 new employees.
  • Inducement grants support recruitment efforts.
  • RSUs vesting over four years incentivizes long-term commitment.

Full Press Release Details

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of inducement grants. On November 5, 2026, as an inducement material to acceptance of employment with CareDx, 21 new employees were awarded restricted stock units (RSUs) for an aggregate of 33,375 shares of common stock. The RSUs will vest over four years, with 25% of the RSUs vesting on the first anniver

Frequently Asked Questions

What are the inducement grants by CareDx?

CareDx awarded inducement grants in the form of RSUs to new employees.

How many employees received RSUs?

A total of 21 new employees received RSUs from CareDx.

What is the total number of shares awarded?

The total number of shares awarded is 33,375.

How long will the RSUs vest?

The RSUs will vest over four years.

ShareAdd on Google
Tags: CDNA CareDx inducement grants restricted stock units Nasdaq
Last updated: Nov 6, 2026

Biotech snapshot

Cash runway
$250M liquidity · $0M/mo burn
Low dilution risk